Gemini’s Stock Falls After IPO as Q3 Losses Mount Despite Revenue Growth
Gemini’s shares drop 16% after Q3 results show $159.5M loss. Despite record credit card growth and rising revenue, high marketing costs weigh on results.
Gemini’s shares drop 16% after Q3 results show $159.5M loss. Despite record credit card growth and rising revenue, high marketing costs weigh on results.
Wave Life Sciences' WVE-007 (INHBE-targeted) showed ~5% total fat reduction and 14% visceral fat drop with muscle preserved after one dose. Early results are modest (1% weight loss), but support infrequent dosing as potential GLP-1 complement.
Equitable and Corebridge will merge in a $22 billion all-stock deal to create a major retirement and life insurance company with $1.5 trillion in assets. The deal is expected to close by end of 2026.
Shareholders filed a lawsuit against Super Micro Computer, accusing the company of securities fraud by concealing risky sales to China that violated U.S. export laws.